Detection of SYT-SSX fusion gene product in tissue section.
Project/Area Number |
15K19051
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Human pathology
|
Research Institution | Gifu University |
Principal Investigator |
Saigo Chiemi 岐阜大学, 大学院医学系研究科, 助教 (10547681)
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2015: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
|
Keywords | 滑膜肉腫 / 特異抗体 / 軟部腫瘍 / SYT-SSX / SS18-SSX / in situ PLA / SS18 / SYT / SSX |
Outline of Final Research Achievements |
Synovial sarcoma is an aggressive sarcoma with specific reciprocal chromosomal translocation of SS18 (also known as SYT) and SSX genes. In the present study, we aimed to detect the SS18-SSX fusion gene product in routinely processed pathological synovial sarcoma tissue section. Monoclonal antibodies to amino acids peptide, which covered the fusion region of SS18-SSX, were newly established and subsequently characterized by Enzyme-Linked ImmunoSorbent Assay, Western-immunoblotting, and Immunohistochemical staining. We generated over thirty antibodies, which immunostained SS18-SSX gene product in routinely processed formalin-fixed and paraffin-embedded tissue section; however, most antibodies exhibited the cross reactivity with SS18 and/or SSX proteins as well as SS18-SSX chimera protein. By contrast, a monoclonal antibody designated AS1SS, preferably reacted with boundary region of SS18-SSX chimera protein.
|
Report
(3 results)
Research Products
(4 results)
-
-
-
[Journal Article] Downregulation of ARID1A, a component of the SWI/SNF chromatin remodeling complex, in breast cancer.2016
Author(s)
Takao C, Morikawa A, Ohkubo H, Kito Y, Saigo C, Sakuratani T, Futamura M, Takeuchi T, Yoshida K.
-
Journal Title
J. Cancer
Volume: 8
Issue: 1
Pages: 1-8
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-